# A Prospective, Clinical Trial of the TANTALUS® System in Treatment of Obese to Morbidly Obese Patients

> **NCT00779363** · NA · COMPLETED · sponsor: **MetaCure (USA), Inc.** · enrollment: 14 (actual)

## Conditions studied

- Type 2 Diabetes
- Obesity

## Interventions

- **DEVICE:** rechargeable TANTALUS II

## Key facts

- **NCT ID:** NCT00779363
- **Lead sponsor:** MetaCure (USA), Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2016-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00779363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00779363, "A Prospective, Clinical Trial of the TANTALUS® System in Treatment of Obese to Morbidly Obese Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00779363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*